1-15 of 732
Understanding the Emotional Impact of Pediatric Skin Disease
On the Frontlines of Pediatric Skin HealthUnderstanding the Emotional Impact of Pediatric Skin Disease
Cheryl Bayart, MD, MPH
Recognizing the Mental Burden of Psoriasis
On the Frontlines of PsoriasisRecognizing the Mental Burden of Psoriasis
Mio Nakamura, MD, MS
Steve Jackson, PharmD
Challenging the Status Quo in Schizophrenia Treatment
On the Frontlines of SchizophreniaChallenging the Status Quo in Schizophrenia Treatment
Shelina Ramnarine, PhD
Stephen Marder, MD
The Social Brain in Schizophrenia
On the Frontlines of SchizophreniaThe Social Brain in Schizophrenia
Shelina Ramnarine, PhD
Michael Green, PhD
Addressing Social and Systemic Barriers in Schizophrenia
On the Frontlines of SchizophreniaAddressing Social and Systemic Barriers in Schizophrenia
Shelina Ramnarine, PhD
Margaret Emerson, DNP, APRN, PMHNP-BC
Nutrition and the Gut-Brain Connection in Schizophrenia
On the Frontlines of SchizophreniaNutrition and the Gut-Brain Connection in Schizophrenia
Shelina Ramnarine, PhD
Deanna L. Kelly, PharmD, BCPP
- advertisement
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
On the Frontlines of SchizophreniaDelivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
Alexandria May, PharmD, BCPS
Apurva Bhatt, MD
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
NeuroFrontiersAddressing the Hidden Burden of Negative Symptoms in Schizophrenia
Alexandria May, PharmD, BCPS
Michael Halassa, MD, PhD
How Muscarinic Therapies Are Redefining Schizophrenia Care
NeuroFrontiersHow Muscarinic Therapies Are Redefining Schizophrenia Care
Michael Halassa, MD, PhD
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiersDetecting Schizophrenia Early: Clinical Challenges and Future Directions
Jeffrey A. Lieberman, MD
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
NeuroFrontiersOvercoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Charles Turck, PharmD, BCPS, BCCCP
Tushita Mayanil, MBBS (MD)
Melanie Yabs, PharmD, MS, BCPP
- advertisement
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
NeuroFrontiersSupporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Charles Turck, PharmD, BCPS, BCCCP
Hannah Brown, MD
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
NeuroFrontiersBeyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Ashley Baker, MSN, PMHNP
Stephen Marder, MD
Identifying and Managing Violence Risk in Schizophrenia Care
On the Frontlines of SchizophreniaIdentifying and Managing Violence Risk in Schizophrenia Care
Alexandria May, PharmD, BCPS
Ragy R. Girgis, MD, MS
